Femoropopliteal Occlusive Disease
7
0
1
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
1 terminated out of 7 trials
66.7%
-19.8% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
The Efficacy of Endovascular Treatment in FPOD With TASC C and D Lesions
Endovascular Treatment of Peripheral Artery Disease (PAD)
Treatment of Patients With Lesions in the Superficial Femoral and/ or Popliteal Arteries Using Kanshas Paclitaxel-coated Balloon Catheter.
Efficacy and Safety of Interwoven Self-Expandable Nitinol Stent for Femropopliteal Arterial Occlusive Diseases
Endovascular Treatment of Peripheral Artery Disease
Accessing Peripheral Occluded LesiOns II (APOLO-II)
New Anastomotic Device for End to End Vascular Anastomosis in the Treatment of Peripheral Vascular Disease